Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin

EU orphan designation number: EU/3/15/1603   
Active ingredient: Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin
Indication: Treatment of pancreatic cancer
Sponsor: Aduro Biotech Holdings, Europe B.V.
Pivot Park RX 1101, Molenweg 79, 5349 AC Oss, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/01/2016 Orphan designation EMA/OD/168/15 (2016)156 of 11/01/2016
15/04/2016 Transfer of orphan designation EMA/OD/168/15/T/01 (2016)2263 of 13/04/2016